Legal Opinion
Gilliland v. Novartis Pharmaceuticals Corp.
District Court, S.D. Iowa
Decided July 25, 2014No. 1:12-cv-00029PublishedCited by 6 opinions
1Opinion of the Court
ORDER
ROBERT W. PRATT, District Judge.
Before the Court are the following two motions by Novartis Pharmaceuticals Corporation (“Novartis”), both filed May 15, 2014: (1) Motion to Exclude Testimony of Dr. Eric Sung, D.D.S. (“Dr. Sung”) (“Motion to Exclude”) (Clerk’s No. 79)1; and (2) Motion for Summary Judgment (Clerk’s No. 83)2 (collectively “Novartis’s *962Motions”). Denise Gilliland (“Gilliland”) responded to each Motion on June 16, 2014. Clerk’s Nos. 88, 93. Novartis replied on June 30, 2014. Clerk’s Nos. 100, 102. On July 3, 2014, Novartis filed a Notice of Supplemental Authorities in Support…
2Cases cited40 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Kumho Tire Co. v. CarmichaelSupreme Court of the United States · 1999
- Parklane Hosiery Co. v. ShoreSupreme Court of the United States · 1979
35 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- Charolette Payne v. Novartis Pharm. Corp.Court of Appeals for the Sixth Circuit · 2014
- Himes v. Somatics, LLCCalifornia Supreme Court · 2024
- In Re: RFC and RESCAP Liquidating Trust LitigationDistrict Court, D. Minnesota · 2018
- In Re: RFC and RESCAP Liquidating Trust LitigationDistrict Court, D. Minnesota · 2020
- Kelly v. Ethicon, Inc.District Court, N.D. Iowa · 2020
1 more not listed; retrieve them via the Exa API.